Cancer research benefits from utilising real world data (RWD)
18 April 2022
- “COTA is committed to creating a precise, patient-first approach to cancer care through the use of real-world evidence.”
- “Another critical issue that real-world data is beginning to help solve is the lack of diversity in clinical trials…We use real-world data to explore differences in tumour biology. Treatment patterns, and outcomes to further characterise disparities in underrepresented and underserved populations.”
- “Offering the highest quality oncology real-world data from leading academic and community-based cancer centers ensures that everyone touched by cancer has a clear path to the right care.”
Vice President of Life Sciences COTA inc.Click here to learn more.